About Akava Therapeutics
Akava Therapeutics is a private company based in Winnetka, Illinois. It has reported $100,000 raised in four offerings on Form D since March 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Not yet | Feb 19, 2026 | $0of $15.0M target | 0 | — | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Feb 5, 2025 | Feb 21, 2025 | $100,000of $500K target | 1 | $100K | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Not yet | Apr 23, 2024 | $0of $5.0M target | 0 | — | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Not yet | Mar 3, 2023 | $0of $10.0M target | 0 | — | OptionsRule 506(c) | Form D ↗ |
| Total, four offerings | $100,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Akava Therapeutics's Form D filed Feb 19, 2026.
RS
Richard Silverman
Executive officer and director
CP
Charles Polsky
Executive officer and director
JN
Joseph Nolan
Director
BM
Brendan MacMillan
Director
PS
Philip Silverman
Secretary and director